HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals (NASDAQ:NRXP), announced Thursday its plans to acquire Kadima Neuropsychiatry Institute, a La Jolla, CA-based interventional psychiatric ...

Medical and technology-focused company HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals, is set to acquire the Kadima Neuropsychiatry Institute, based in La Jolla, California, US.